chrisvoncsefalvay/vaers-outcomes huggingface dataset:
20 hours after receiving vaccine the following symptoms began: extreme fatigue, headache, chills, sweating, swelling of the lymph node at my collar bone on the left side of my neck. Symptoms subsided 30 hours after onset except for the lymph node swelling. 72 hours after receiving  vaccine left lymph node at clavicle became hard and came to the skin surface. It is about the size of a large pea. The swelling around the area slowly increased over the next few. The node is painful and the swollen area is tender. The tenderness spread down my chest and out toward my should. The total area of tenderness is about 4 inches in diameter. The status is the same today.
approximately 5 mins after recieving 2nd dose member began to have a seizure eyes open , no responsive with right arm and leg tremors. Pulse 100.  lasted 5-8 minutes.  Hx of seizure with does of HPV in  2014
Tingling on the left side of my face and my hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 01Apr2021 08:30 (Lot number: EP6955) at the age of 60 years as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "Hypertension" (ongoing); "Low potassium" (ongoing); "High cholesterol" (ongoing); "Anxiety" (ongoing). Concomitant medication(s) included: METOPROLOL taken for hypertension (ongoing); AMLODIPINE taken for hypertension (ongoing); KLOR-CON taken for blood potassium decreased (ongoing); ROSUVASTATIN taken for hypertension (ongoing); BUPROPION taken for anxiety (ongoing). The following information was reported: PARAESTHESIA (non-serious) with onset 01Apr2021, outcome "unknown", described as "Tingling on the left side of my face and my hand".  No follow-up attempts are possible. No further information is expected.
Information has been received from a pharmacist concerning a patient (demographics unknown) who, on a unspecified date, was vaccinated with one dose of pneumococcal vaccine 23 polyvalent (lot # 637263/1448K). It was reported that, on an unspecified date, the patient developed red streaking from the injection site, down the arm, but did not require hospitalization. Unspecified medical attention was sought. The reporter had no further information at the time of report. The records of testing prior to the release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
This non-serious medically confirmed spontaneous report (initial receipt 27-MAY-2015) concerns a 29 year-old non-pregnant female patient. The patient had medical history of screening for pulmonary TB, vaccine against tetanus and flue vaccine. On 27-MAY-2015, the patient received one dose of expired AFLURIA (batch number T57105) via the intramuscular route. On the same day, the patient also received BOOSTRIX (batch number  not provided) on another arm, and TB skin test (batch number not provided) on the same arm as the AFLURIA injection. The outcome was not provided. Reporters comments: The reporter insisted that no patient harm occurred.
pt recvd vax in morning later on in day had fever of 102.4;sz began 7-8hrs p/shot-was taken to hosp fever 104-given spinal tap & rx for Amoxil & Ibuprofen susp-pt irritable;return to clinic 20SEP95
hot and cold flu-like" condition; diarrhea; vomiting; little soreness in his arm, where he had the shot; did not feel good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 62-years-old male patient received bnt162b2 (BNT162B2), administration date 31Mar2021 14:30 (Batch/Lot number: unknown) at the age of 62 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 31Mar2021, outcome "unknown", described as "did not feel good"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "hot and cold flu-like" condition"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhoea"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; VACCINATION SITE PAIN (non-serious) with onset 31Mar2021 14:30, outcome "recovered" (2021), described as "little soreness in his arm, where he had the shot". Therapeutic measures were not taken as a result of influenza like illness, diarrhoea, vomiting, vaccination site pain.  Additional Information: Caller/Consumer said that he had a couple of questions and concerns, after he received the first dose of the PFIZER-BIONTECH COVID-19 Vaccine last Wednesday on 31Mar2021, at 2:30pm in the afternoon. At around 6:00pm, he mentioned that his injection arm was sore, where he had the shot and he understands this was typical. He also stated that he did not feel good that night and until a few more days. He asked about a hot and cold flu-like condition, diarrhoea, vomiting. He says his first question was that in a ballpark figure, how long does it take to get pain in the arm, he thought it would be within the first hour. He also asked if the vaccine was a two dose series. He said on his handwritten vaccine card NDC/EXP were not provided. About adverse event treatment: None. About outcome: Left arm soreness went away. About concomitant medications: He said they have not had any other recent vaccinations or started any new medications.  No follow-up attempts are possible. No further information is expected.
Generalized stiffness and inability to open mouth in 7/13/05 (vaccine received 7/8/05).
This spontaneous report as received from a consumer refers to a 13 year old male patient with prophylaxis. On 29-DEC-2005 the patient was vaccinated with M-M-R II for prophylaxis. Other suspect therapies included DTaP, poliovirus vaccine inactivated (unspecified), PEDVAXHIB, VARIVAX and PNEUMOVAX 23. On 29-DEC-2005 the patient experienced vaccination site mass and drug administered to patient of inappropriate age. On an unknown date the patient experienced muscle twitching. The outcome of muscle twitching, drug administered to patient of inappropriate age and vaccination site mass is unknown. The reporter considered vaccination site mass to be related to PEDVAXHIB, VARIVAX, M-M-R II and PNEUMOVAX 23. The reporter considered muscle twitching to be related to M-M-R II, VARIVAX, PEDVAXHIB and PNEUMOVAX 23. The reporter considered drug administered to patient of inappropriate age to be related to M-M-R II, VARIVAX, PNEUMOVAX 23 and PEDVAXHIB. Additional information has been requested.
Inconsolable crying, pallor, & loss of consciousness, 8 hrs after being given immunization for the first time.
This spontaneous report as received from a registered nurse via Medical Record refers to a 13 months old female patient with no known drug allergies (NKDA). The patients current conditions included: gastro esophageal reflux disease (GERD) and umbilical hernia. On 17-MAR-2013, the patient was vaccinated with the First dose of Hepatitis B virus vaccine (unspecified) for Hep B. On 22-MAY-2013, the patient was vaccinated with the first dose of PEDIARIX; First dose of ACTHIB; First dose of PREVENAR 13; First dose of ROTARIX. On 19-JUL-2013, the patent was vaccinated with the second dose of DAPTACEL; second dose of ACTHIB; Second dose of PREVENAR 13; Second dose of ROTARIX. On 26-SEP-2013, the patient was vaccinated with the Third dose of PEDIARIX; third dose of ACTHIB; Third dose of PREVENAR 13. On 17-JAN-2014, the patient was vaccinated with the First dose of FLUZONE; Third dose of IPOL. On 24-MAR-2014 at 09:45 am, the patient was vaccinated with the first dose of (Oka/Merck) PROQUAD (lot # J015312, expiry date: 03-JUN-2015) (dose and route of administration not reported) which was stored improperly, exposed to 42F for 4 weeks. It was reported that the patient did not seek medical attention. On the same date, the patient was vaccinated concomitantly with the first dose of HAVRIX; Second dose of FLUZONE; Fourth dose of PREVENAR 13 and (Oka/Merck) VARIVAX (dose and lot# not reported). On 28-APR-2014, the patient was vaccinated with PEDVAXHIB. This is one of several reports from the same source. Pediatric medical records were received and reviewed; no adverse experiences related to the prenatal exposure or to other Merck Products were identified. All available medical records will be provided upon request. Additional information is not expected.
A consumer report has been received concerning a female patient. Patient relevant history, concurrent diseases and concomitant drugs were not reported. Participant in research said that, after taking FLUMIST (intranasal) during Sep-2015, she contracted influenza. She believed FLUMIST was the cause. The patient recovered from influenza during Sep-2014. The report was considered to be non-serious. Participant in research said that, after taking FLUMIST, she contracted influenza. She believed FLUMIST was the cause.
Patient states she felt discomfort from time of vaccination. Reports deep pain in muscle and joint of right arm. Patient has self-treated with NSAID, VOLTAREN gel and Lidocaine ointment which does help but pain has persisted and limits her activity. Injection site is without signs of infection or muscle, wasting per Dr. Patient to continue supportive measures and will refer to ortho if persists.
Patient developed arthralgias 3 days after second dose of Moderna vaccine and they have not subsided or gotten better. Patient continues to endorse joint pain 4 weeks after vaccine,
shot in her left arm/Her left arm and face went numb; face went numb; headache; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A female patient of an unspecified age (61, age unit unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on left arm on 05Feb2021 (between 11:00 and 12:00) at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the shot in her left arm. Her left arm and face went numb and she has a terrible headache, all in Feb2021. She stated this were still occurring. The patient asked if these were normal side effects and if there was anything she could take for it. The patient considered the events as non-serious. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; From cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful.; Tonsil on right side is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 15Sep2021 16:00 (Lot number: FF2588) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 15Sep2021, outcome "not recovered", described as "Tonsil on right side is sore"; SWELLING FACE (non-serious), SWELLING (non-serious), LYMPHADENOPATHY (non-serious) all with onset 16Sep2021, outcome "not recovered" and all described as "Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes"; FACIAL PAIN (non-serious) with onset 16Sep2021, outcome "not recovered", described as "From cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful".  Additional Information: The Caller states that she is calling about the Pfizer Product was Comirnaty. Caller states she was had side effects. She took the first shot on Wednesday in the afternoon at 16:00. That night her tonsil on the right side was sore. That morning she got up and her whole right side of her jawline, from cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful. Caller states was has been two days, she called her doctor and they suggested she call Pfizer to report her symptoms. Event Details was Caller states that her symptoms was all persisting. Caller states she does not know if she has any other medications or medical conditions relevant to these events. Any AE(s) require a visit to Emergency Room, Physician Office was No. caller States she only called her doctor and did not visit office. The patient does not receive any other vaccines within 4 weeks prior to the COVID vaccine. The AE(s) following prior vaccinations was none. History of all previous immunization with the Pfizer vaccine considered as suspect(or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) reported as none. Additional Vaccines Administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect reported as none. Family Medical History Relevant to AE(s): None. Relevant Tests: None.  No follow-up attempts are possible. No further information is expected.
Itchy throat and back of tongue, received IM epi, pt complaints unchanged <5 min after epi inj, received diphenhydramine, famotidine, prednisone (1 hr later), patient comfortable, throat symptoms improving (2.5 hrs later)
Cellulitis, Myalgias- went to Immediate care- treated with Keflex 500mg Q 8 hours x10days.
sore arm at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, 1 day after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of Shingrix 4 months before the date of reporting. The patient experienced a sore arm at the injection site. The patient stated that the injection site pain had improved over the last 4 months, but that it had not completely resolved till the time of reporting. The patient went to see the doctor about the arm soreness. The patient consented to follow up.
RIGHT UPPER LATERAL THIGH WITH APPROXIMATELY 8 CM AREA OF INDURATION, ERYTHEMA AND CENTRAL VESICLES
Information has been received from a physician concerning his 72 year old mother with a history of diverticulitis who "three weeks ago" on approximately 01-JAN-2008 was vaccinated with a single dose of ZOSTAVAX (Oka/Merck). "Five days ago" on approximately 18-JAN-2008 the patient developed flank pain and skin sensitivity on the right side in her ribcage area that he estimated (from a description over the phone) to be at the T7-8 dermatome level. This was also reported as a "shingles like reaction" however, there was no rash at that time. The patient was taking ibuprofen. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support. A contactable male consumer or other non-health care professional (Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), via an unspecified route of administration on 30Jan2021 as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced he has been having headaches off and on an unspecified date of 2021. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
as soon as the Pentacel was given  patient immediately turned red, became irritable unconsolably,  then few minutes later his right leg became swollen  then left started to swell as well and he started to develop hives on his arm at the sight of injection
After first shot had palpitations and nausea for 24 hours. ( I did report prior to taking second dose) After second shot developed shortness of breath and nausea.  Particularly bad with having to don mask. Did not go to ER or doctor. Has resolved somewhat' but still not able to tolerate mask.
tongue swelling; sore arm; dehydration; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer Sales Representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that after receiving the first dose of the Pfizer COVID-19 vaccine, she had tongue swelling, dehydration for approximately 45 minutes, and a sore arm. Patient reported being fine after this. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Itching and red rash at injection site. Started feeling run down, then headache and, during late night, 102.5 fever and stabbing body aches. Subsided by the next morning beyond lingering headache and tiredness. Arm rash and itching still present.
tongue is swelling a bit that she cannot see the uvula when she opens her mouth; hives around her neck; body temperature is now 100 degrees Fahrenheit; A bit nauseous; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (tongue is swelling a bit that she cannot see the uvula when she opens her mouth), URTICARIA (hives around her neck), BODY TEMPERATURE INCREASED (body temperature is now 100 degrees Fahrenheit) and NAUSEA (A bit nauseous) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 040C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Sep-2021, the patient experienced SWOLLEN TONGUE (tongue is swelling a bit that she cannot see the uvula when she opens her mouth), URTICARIA (hives around her neck), BODY TEMPERATURE INCREASED (body temperature is now 100 degrees Fahrenheit) and NAUSEA (A bit nauseous). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (tongue is swelling a bit that she cannot see the uvula when she opens her mouth) had not resolved and URTICARIA (hives around her neck), BODY TEMPERATURE INCREASED (body temperature is now 100 degrees Fahrenheit) and NAUSEA (A bit nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 degrees fahrenheit (High) 100 degrees Fahrenheit.         No concomitant medications were provided.
I started having muscle Weakness and lower joint pain with a pinched nerve and a lot of fatigue in the muscles doc-feb were really bad but are getting better.
No reaction to the vaccine, but I got COVID-19, I had a home test, when I was traveling, head cold, stuffy nose, rash spread in different parts of my body, it lasted for 10 days. I had ear problems and I saw a doctor; she said I had fluid on the ear and gave me medicine for 9 days, I was flying so I was worried, but everything was okay.
Pt recvd 2 doses of Engerix-B & the next day p/2nd dose exp abdominal pain & vomiting;
PAIN ON THE BACK; twitches before onset of pain; still having pain from shingles off and on; This case was reported by a other health professional via call center representative and described the occurrence of back pain in a 87-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles (Active case of shingles a year and half ago from the date of reporting) and neuralgia (Occurred a year and half ago from the date of reporting).   In September 2021, the patient received the 1st dose of Shingrix. In September 2021, 3 days after receiving Shingrix, the patient experienced back pain, twitching and pain. The patient was treated with tramadol. On an unknown date, the outcome of the back pain and pain were not recovered/not resolved and the outcome of the twitching was unknown.   It was unknown if the reporter considered the back pain and twitching to be related to Shingrix. The reporter considered the pain to be unrelated to Shingrix.   Additional details were reported as follows: The age at vaccination was not reported. 2 weeks ago, from the date of reporting, the patient received Shingrix. Less than 2 weeks after vaccination, a year later the patient still had pain from shingles off and on.  The patient complained pain on her back triggered 3 days from 1st dose of Shingrix which was 3 weeks ago (from another pharmacy).  Less than a weeks after vaccination, the patient twitches before onset of pain.  The patient taken tramadol to ease pain and had to take more pills. The reporter consented to follow up. No other details of vaccine available. Note: Event pain was conservatively added as it was not clear if it was started before or after vaccination and causality not related as it was related to shingles (medical history).
Immediately post vax, the pt started running a fever, cough, congestion, loss of appetite. By 2/14/96, the pt was hospitalized with high fever and paralyzed. She was hospital for two weeks and dx with transverse myelitis. Given antibiotics, IV IGG, and steroids. The pt was paralyzed from the waist down. Numerous bronchoscopies to open collapsed lung due to stomach muscles not developing. Now confined to a wheel chair. Per doc 203594 received 11/19/2001, patient is still disabled. She has no voluntary movement below the waist and limited movement of both arms. She is 6 years old and is confined to a wheel chair. She has reoccuring long troubles and relies on daily breathing treatments with Asma. Mentally she is bright and a very happy child.
Dizziness, diaphoretic, lightheaded. Patient described "Feeling high".  Nurse sat with for approximately 40 minutes. Took vitals twice and were within normal range. Patient relaxed and drank water. Patient reported feeling good. Vitals were taken again and was good.